Below are the most recent publications written about "Antigens, Protozoan" by people in Profiles.
-
Jesus MM, Lage DP, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, Ludolf F, Tavares GSV, Galdino AS, Duarte MC, Menezes-Souza D, Ch?vez-Fumagalli MA, Teixeira AL, Gon?alves DU, Roatt BM, Christodoulides M, Martins VT, Coelho EAF. Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis. Parasitol Res. 2023 Dec; 122(12):2917-2931.
-
Kayatani AKK, Bobbili N, Megnekou R, Matsunaga M, Leke RFG, Taylor DW. Are high avidity antibodies to Plasmodium falciparum antigens preferentially transferred across the placenta of premature and term babies? Placenta. 2023 09 07; 140:11-19.
-
Tassi Yunga S, Siriwardhana C, Fouda GG, Bobbili N, Sama G, Chen JJ, Leke RFG, Taylor DW. Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area. Malar J. 2022 Nov 19; 21(1):346.
-
Kayatani AKK, Leke RGF, Leke RIJ, Fogako J, Taylor DW. Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and term. Sci Rep. 2022 11 07; 12(1):18864.
-
McGovern KE, Nance JP, David CN, Harrison RES, Noor S, Worth D, Landrith TA, Obenaus A, Carson MJ, Morikis D, Wilson EH. SPARC coordinates extracellular matrix remodeling and efficient recruitment to and migration of antigen-specific T cells in the brain following infection. Sci Rep. 2021 02 25; 11(1):4549.
-
Oliveira-da-Silva JA, Machado AS, Ramos FF, Tavares GSV, Lage DP, Mendon?a DVC, Pereira IAG, Santos TTO, Martins VT, Carvalho LM, Freitas CS, Ludolf F, Reis TAR, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis. Cell Immunol. 2020 10; 356:104194.
-
Oliveira-da-Silva JA, Lage DP, Ramos FF, Machado AS, Tavares GSV, Mendon?a DVC, Pereira IAG, Martins VT, Carvalho LM, Ludolf F, Santos TTO, Reis TAR, Oliveira CS, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Menezes-Souza D, Roatt BM, Teixeira AL, Coelho EAF. Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis. Mol Immunol. 2020 08; 124:161-171.
-
Ribeiro PAF, Dias DS, Lage DP, Mendon?a DVC, Vale DL, Ramos FF, Carvalho LM, Carvalho AMRS, Steiner BT, Roque MC, Oliveira-da-Silva JA, Oliveira JS, Tavares GSV, Martins VT, Ch?vez-Fumagalli MA, Roatt BM, Moreira RLF, Menezes-Souza D, Duarte MC, Oliveira MC, Machado-de-?vila RA, Teixeira AL, Coelho EAF. Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells. Parasitol Res. 2020 Aug; 119(8):2609-2622.
-
Taylor DW, Bobbili N, Kayatani A, Tassi Yunga S, Kidima W, Leke RFG. Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach. Malar J. 2020 May 01; 19(1):171.
-
Lage DP, Machado AS, Ramos FF, Silveira PC, Dias DS, Ribeiro PAF, Tavares GSV, Costa LE, Santos TTO, Steiner BT, Fagundes MI, Ch?vez-Fumagalli MA, Lyon S, Moreira RLF, Duarte MC, Menezes-Souza D, Caligiorne RB, Machado-de-?vila RA, Teixeira AL, Coelho EAF. A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein. Immunobiology. 2019 07; 224(4):477-484.